Sponsor Pipeline

Huahui Health Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
2
Phase 3
10
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07499544 A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With… Chronic Hepatitis D Infection Recruiting
NCT05787418 HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2 COVID-19 Enrolling by Invitation
Phase 2
NCT07519330 Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic… Chronic Hepatitis B Virus Infection Recruiting
Phase 1/2
NCT07547553 A Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of… Advanced or Unresectable Hepatocellular Carcinoma (HCC) Recruiting
Phase 1
NCT07623369 A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors Solid Tumor Not Yet Recruiting
Disease Areas
Liver Cancer (2) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Breast Cancer (1) Triple-Negative Breast Cancer (1) Colorectal Cancer (1) Kidney Cancer (1) Bladder Cancer (1) Cervical Cancer (1) Endometrial Cancer (1)
Get alerts when Huahui Health's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free